US Bancorp DE trimmed its position in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) by 19.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,051 shares of the company’s stock after selling 4,733 shares during the period. US Bancorp DE’s holdings in Oscar Health were worth $269,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. KBC Group NV boosted its stake in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after buying an additional 2,555 shares during the period. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health during the 4th quarter valued at $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health during the 4th quarter valued at $138,000. SMART Wealth LLC acquired a new stake in shares of Oscar Health during the 4th quarter valued at $180,000. Finally, Tempus Wealth Planning LLC acquired a new stake in shares of Oscar Health during the 4th quarter valued at $181,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities research analysts have issued reports on OSCR shares. Jefferies Financial Group started coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $20.00 to $16.00 in a research note on Thursday. Two analysts have rated the stock with a sell rating, three have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $20.19.
Oscar Health Stock Up 2.7 %
OSCR stock opened at $13.23 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1 year low of $12.43 and a 1 year high of $23.79. The company has a fifty day simple moving average of $15.21 and a 200 day simple moving average of $16.39. The firm has a market cap of $3.31 billion, a PE ratio of -660.92 and a beta of 1.75.
Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Oscar Health Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Read More
- Five stocks we like better than Oscar Health
- How to Use the MarketBeat Dividend Calculator
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Short Selling – The Pros and Cons
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.